ADVENTHEALTH ORLANDO
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $84.3M
- Transactions
- 11,498
- Companies
- 40
- Average per transaction
- $7,328
Who reported the payments
| Merck | $10,931,303 |
| Eli Lilly | $10,875,855 |
| Pfizer | $4,930,723 |
| Boston Scientific | $3,504,890 |
| Olympus Corporation Of The Americas | $3,097,714 |
| AVEO Pharmaceuticals, Inc. | $3,090,400 |
| AbbVie | $2,546,070 |
| Medical Device Business Services, Inc. | $2,396,666 |
| Abbott | $2,227,313 |
| Amgen | $1,903,735 |
| Seagen Inc. | $1,787,785 |
| AstraZeneca | $1,736,265 |
| Sanofi US Services Inc. | $1,664,666 |
| Intuitive Surgical | $1,562,738 |
| Medtronic | $1,515,434 |
| Janssen Research & Development, LLC | $1,495,919 |
| Novartis | $1,491,606 |
| Edwards Lifesciences | $1,363,568 |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,220,002 |
| Genentech, Inc. | $1,055,448 |
| Gilead | $931,031 |
| Beigene, Ltd. | $828,851 |
| Bristol Myers Squibb | $777,613 |
| Exelixis Inc. | $762,556 |
| Daiichi Sankyo Inc. | $756,976 |
| Bayer | $712,886 |
| Stryker | $630,903 |
| F. Hoffmann-la Roche AG | $597,339 |
| Regeneron | $562,941 |
| E.r. Squibb & Sons, L.L.C. | $552,738 |
| Cvrx, Inc. | $504,431 |
| Biotronik Inc. | $503,934 |
| Asensus Surgical, Inc. | $478,848 |
| Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. | $473,474 |
| Genmab U.S., Inc. | $426,573 |
| Histosonics, Inc. | $408,162 |
| Novo Nordisk AS | $395,262 |
| Applied Medical Resources Corporation | $395,211 |
| Johnson & Johnson | $394,750 |
| Cardiovascular Systems Inc. | $374,698 |